An integrated strategy for Life Sciences in Europe (Invited Guests)

4 Jun 2020 10.30 CEST - 4 Jun 2020 12.00 CEST

Healthcare

All Committees

An integrated strategy for Life Sciences in Europe - towards more resilient health systems

To join the event please click here

In recent months the global COVID-19 pandemic has put the health systems across Europe under tremendous pressure and its effects are sure to reverberate for a long time to come. As Europe begins to recover from the crisis, the focus must be on the rebuilding of strong healthcare for the future. In that context, we have taken a fresh look at AmCham EU’s Life Sciences for Europe report to propose innovative solutions to increase the resilience of health systems. Innovation in pharmaceuticals, medical devices, diagnostic technologies and digital health has revolutionised the healthcare sector, bringing groundbreaking benefits to patients. The integration of these technologies can also pose novel common challenges. At AmCham EU, we believe that in the current context it has never been more important to discuss these challenges and solutions for an integrated approach to the life sciences sector. As governments and the EU look at restarting the economy, the time is ripe to invest in future-proofing our health systems for the benefit of all citizens.

Speakers:

•	Anthony Barron, Principal in the Life Sciences Practice, Charles River Associates (author of the study)
•	Charis Girvalaki, MPH, PhD, EU Affairs Manager, European Cancer Patient Coalition
•	Andrzej Rys, Director responsible for Health systems, medical products and innovation, DG SANTE, European Commission
•	Susana Solís Pérez, MEP (Renew Europe, ES), European Parliament